IP Library Assignment 061113/0710
Patent Assignment
Reel/Frame 061113/0710

Change of Address

Recorded: 2022-06-27 Pages: 6
Assignor
GALDERMA HOLDING SA
Executed: 2022-02-17
Assignee
GALDERMA HOLDING SA
ZÄHLERWEG 10, ZUG, 6300, SWITZERLAND
Covered Properties (38)
Bpo Wash Emulsion Composition
Application: 14/442,698 →
Publication: US 2016/0206590
Lubrication of an Injection Needle
Application: 15/114,598 →
Publication: US 2016/0339185
Atrophic Acne Scar Risk Assessment Tool
Application: 15/875,508 →
Publication: US 2018/0206778
Systems and Methods for Itch Monitoring and Measurement
Application: 15/893,278 →
Publication: US 2018/0228427
Method for Deacetylation of Biopolymers
Application: 16/066,746 →
Publication: US 2019/0016830
Carbohydrate Crosslinker
Application: 16/066,810 →
Publication: US 2019/0023812
Syringe
Application: 16/066,900 →
Publication: US 2019/0001068
Compositions Comprising a Compound of the Avermectin Family for the Treatment and/or Prevention of Hand Eczema
Application: 16/347,155 →
Publication: US 2020/0054599
Flexibility Measurements of Injectable Gels
Application: 16/466,364 →
Publication: US 2020/0072721
Method of Soft Tissue Augmentation
Application: 16/593,941 →
Publication: US 2020/0030494
Method of Preparing a Hydrogel Product
Application: 16/729,179 →
Publication: US 2020/0140626
Treatment of Skin Lesions and Pruritus in Prurigo Nodularis Patients
Application: 16/773,538 →
Publication: US 2020/0239563
Method of Treating Truncal Acne with Trifarotene
Application: 16/854,716 →
Publication: US 2020/0330429
Method of Treating Hand-Foot Syndrome and Symptoms Associated Therewith
Application: 16/867,412 →
Publication: US 2020/0390762
Track-Indexed Syringe
Application: 16/888,110 →
Publication: US 2020/0297932
Injectable Gel Product
Application: 16/907,132 →
Publication: US 2020/0316260
Nemolizumab in the Treatment of Atopic Dermatitis with Moderate to Severe Excoriation
Application: 16/988,554 →
Publication: US 2020/0385476
Ready-To-Use Esthetic Compositions
Application: 17/081,893 →
Publication: US 2021/0121602
Method for Preparing Acylated Crosslinked Glycosaminoglycans
Application: 17/129,366 →
Publication: US 2021/0108036
Process for Efficient Cross-Linking of Hyaluronic Acid
Application: 17/166,909 →
Publication: US 2021/0155763
Modified Release Doxycycline Composition
Application: 17/180,443 →
Publication: US 2022/0031714
Injection Device
Application: 17/213,052 →
Publication: US 2021/0213205
Method for Manufacturing a Shaped Cross-Linked Hyaluronic Acid Product
Application: 17/216,084 →
Publication: US 2021/0214468
Snap-25 Reporter Constructs and Methods of Using the Same
Application: 17/334,119 →
Publication: US 2021/0373021
Post-Crosslinking Partial Degradation of Amide Crosslinked Hydrogels
Application: 17/334,373 →
Publication: US 2021/0284759
Hydrogel Compositions Encapsulating Solid Particles
Application: 17/347,148 →
Publication: US 2021/0308332
Cell Based Method for Determination of Botulinum Toxin Potency Based on Western Blotting
Application: 17/372,236 →
Publication: US 2022/0010355
Novel X-Aptamers for the Use in Detection of SNAP25
Application: 17/458,169 →
Publication: US 2022/0064648
Isopropylcarbonate Benzoyl Peroxide Compositions and Methods of Use
Application: 17/492,320 →
Publication: US 2022/0023250
Method for Deacetylation of Biopolymers
Application: 17/549,450 →
Publication: US 2022/0169804
Treatment of Skin Lesions and Pruritus in Prurigo Nodularis Patients
Application: 17/555,997 →
Publication: US 2022/0177568
Syringe
Patent: 973,203 →
Application: 29/763,036 →
Syringe
Patent: 973,873 →
Application: 29/795,863 →
Syringe Grip
Patent: 1,025,354 →
Application: 29/801,801 →
Treatments for Prurigo Nodularis
Application: 63/172,020 →
Process for the Production of Dath and Intermediates Thereof
Application: 63/189,938 →
Treatments for Atopic Dermatitis
Application: 63/238,643 →
Novel Mtor Inhibitor Compounds
Application: 63/239,353 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 16, 2015
From: NADAU-FOURCADE, KARINE; MAZEAU, LAETITIA
To: GALDERMA S.A.
Reel/Frame 035844/0346 →
Assignment of Assignor's Interest Oct 13, 2016
From: TORNSTEN, JONAS
To: GALDERMA S.A.
Reel/Frame 040008/0718 →
Assignment of Assignor's Interest Jun 22, 2018
From: IKOMA, AKIHIKO
To: NESTLÉ SKIN HEALTH SA
Reel/Frame 046175/0690 →
Assignment of Assignor's Interest Oct 9, 2018
From: MOJARRADI, HOTAN; OLSSON, JOHAN; HARRIS, CRAIG STEVEN; BOITEAU, JEAN-GUY
To: GALDERMA S.A
Reel/Frame 047101/0374 →
Assignment of Assignor's Interest Oct 25, 2018
From: HOLMQVIST, ANDERS; BLOMQVIST, ,AX; TÖRNSTEN, JONAS
To: GALDERMA S.A.
Reel/Frame 047310/0089 →
Assignment of Assignor's Interest Mar 21, 2019
From: OLSSON, JOHAN; HARRIS, CRAIG STEVEN
To: GALDERMA S.A
Reel/Frame 048659/0775 →
Assignment of Assignor's Interest May 5, 2020
From: ANDRES, PHILIPPE
To: GALDERMA S.A.
Reel/Frame 052577/0485 →
Assignment of Assignor's Interest Jun 1, 2020
From: KARLSSON, MORGAN; ÖHRLUND, ÅKE
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 052805/0137 →
Assignment of Assignor's Interest Jun 15, 2020
From: PIKETTY, CHRISTOPHE
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 052944/0734 →
Assignment of Assignor's Interest Jul 30, 2020
From: GERFAUD, THIBAUT; TOMAS, LOIC
To: GALDERMA S.A.
Reel/Frame 053360/0765 →
Corrective Assignment to Correct the Spelling of the Second Assignor's Name Previously Recorded on Reel 047310 Frame 0089. Assignor(S) Hereby Confirms the Assignment. Aug 10, 2020
From: HOLMQVIST, ANDERS; BLOMQVIST, MAX; TÖRNSTEN, JONAS
To: GALDERMA S.A.
Reel/Frame 053451/0214 →
Assignment of Assignor's Interest Oct 7, 2020
From: NORD, LARS; MOJARRADI, HOTAN; OLSSON, JOHAN
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 053994/0424 →
Assignment of Assignor's Interest Oct 7, 2020
From: ÖHRLUND, ÅKE; KARLSSON, MORGAN
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 053998/0636 →
Change of Name Dec 31, 2020
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 054899/0803 →
Assignment of Assignor's Interest Jan 15, 2021
From: ALIO-SAENZ, ALESSANDRA; GRAEBER, MICHAEL; AHMAD, FAIZ
To: NESTLE SKIN HEALTH SA
Reel/Frame 054938/0644 →
Change of Name Jan 15, 2021
From: NESTLE SKIN HEALTH SA
To: GALDERMA HOLDING SA
Reel/Frame 055012/0635 →
Amendment to Asset Transfer Agreement Sep 29, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057652/0859 →
Change of Name Sep 29, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057631/0589 →
Change of Name Oct 3, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057698/0356 →
Asset Transfer Agreement Oct 3, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057698/0295 →
Assignment of Assignor's Interest Nov 26, 2021
From: Q-MED AB
To: NESTLÉ SKIN HEALTH SA
Reel/Frame 058213/0391 →
Assignment of Assignor's Interest Nov 26, 2021
From: ÅGERUP, BENGT
To: Q-MED AB
Reel/Frame 058213/0357 →
Change of Name Nov 26, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 058252/0158 →
Assignment of Assignor's Interest Nov 27, 2021
From: KERROUCHE, NABIL
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058217/0184 →
Assignment of Assignor's Interest Nov 27, 2021
From: KERROUCHE, NABIL
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058217/0169 →